首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1555536

藥物混懸液市場，按類型、適應症、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Pharmaceutical Suspension Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年08月20日 | 出版商:

AnalystView Market Insights | 英文 392 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年藥物混懸劑市場規模為563.4532億美元，2024年至2032年複合年成長率為4.3%。

藥物混懸液市場-市場動態

藥物傳輸技術的進步和研發投入的增加預計將推動市場需求

藥物傳遞系統和製劑技術的創新提高了混懸劑的功效和穩定性。用於製造穩定、高品質混懸劑的改良技術有助於滿足複雜藥物的需求，從而促進市場成長。糖尿病、癌症和呼吸系統疾病等慢性病發病率的增加推動了對各種藥物製劑（包括混懸劑）的需求。這些製劑對於需要液體形式藥物的患者特別有用。此外，製造流程的進步，例如更好的混合和研磨技術，提高了藥物懸浮液的品質和一致性，使其對製造商和消費者都更具吸引力。

製藥公司增加研發投資以創造新的和改進的配方推動了市場成長。這包括開發新藥混懸劑或改進現有產品。此外，由於消費者對方便易得的治療的偏好，對懸浮液形式的非處方藥（OTC）藥物（例如制酸劑、止咳糖漿和止痛藥）的需求持續成長。

藥物混懸液市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.3% 左右的複合年成長率成長

根據類型細分，由於其快速、直接的給藥途徑，預計注射劑細分市場將在 2023 年顯示最大的市場佔有率。

根據適應症細分，由於抗癌藥物的大量供應，癌症細分市場是 2023 年的主要適應症。

根據最終用戶細分，由於癌症和慢性疾病的盛行率不斷增加，醫院細分市場將在 2023 年成為領先的最終用戶細分市場。

按地區分類，由於混懸劑藥物的廣泛供應，北美將成為 2023 年的主要收入來源。

藥物混懸液市場-細分分析：

全球藥物混懸劑市場根據類型、適應症、最終用戶和地區進行細分。

市場依類型分為三類：口服、腸胃外和其他。注射劑細分市場佔據主導地位。腸外藥物配方的進步及其更廣泛的採用主要推動了市場的成長。

根據適應症，市場分為五類：癌症、胃腸道、神經系統、傳染病等。癌症領域佔市場主導地位。治療領域和技術的不斷發展正在刺激細分市場的成長。

根據最終用戶，市場分為三類：醫院、診所和其他。醫院領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。改善的慢性病治療和療法正在促進細分市場的成長。

藥物混懸液市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。亞太地區因其人口眾多、醫療保健支出不斷增加以及慢性病患病率不斷上升而成為一個主要市場。該地區的中國、印度和日本等國家都是重要的藥品製造中心。與其他地區相比，中東和非洲市場相對不發達，但由於醫療保健機會的增加和對各種治療方案的認知不斷提高，人們的興趣與日俱增。

藥物混懸液市場-競爭格局：

藥物混懸劑市場充滿活力，持續的進步和競爭策略塑造了其發展。利用技術創新和策略合作夥伴關係的公司。領先的公司注重創新，以使其產品脫穎而出並保持競爭優勢。這包括開發新配方、改良藥物輸送系統以及投資研發。公司經常與學術機構和研究組織合作，推進藥物傳輸科學並開發創新的混懸液配方。

2023年8月，全球領先的生物製藥公司默克宣布批准ERVEBO的擴大適應症，用於治療一種名為扎伊爾伊波拉病毒的疾病。

2023 年 11 月，梯瓦製藥工業公司 (Teva Pharmaceutical Industries) 和Royalty Pharma plc 合作加速其臨床研究計畫。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美藥物混懸液主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按類型）
- 北美市場規模和預測（按指標）
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲藥物混懸劑主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按類型）
- 歐洲市場規模與預測（按指標）
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區藥物混懸劑主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按類型）
- 亞太地區市場規模與預測（依指標）
- 亞太地區市場規模和預測（按最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲藥物混懸劑主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按類型）
- 拉丁美洲市場規模與預測（按指標）
- 拉丁美洲市場規模和預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲藥混懸劑主要生產商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按類型）
- 中東和非洲市場規模及預測（依指標）
- 中東和非洲市場規模及預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 藥物混懸液產業

競爭儀表板
公司簡介
- Pfizer Inc.
- Johnson & Johnson
- Novartis AG
- GlaxoSmithKline (GSK)
- Sanofi
- Roche
- Merck & Co., Inc.
- Bristol-Myers Squibb
- AbbVie Inc.
- AstraZeneca
- Amgen Inc.
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Dr. Reddy's Laboratories
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV3655

REPORT HIGHLIGHT

Pharmaceutical Suspension Market size was valued at USD 56,345.32 Million in 2023, expanding at a CAGR of 4.3% from 2024 to 2032.

A pharmaceutical suspension is a type of liquid dosage form used in medicine. It consists of solid particles dispersed throughout a liquid medium. Unlike solutions where the active ingredient is fully dissolved, in suspensions, the active ingredient remains undissolved and is suspended in the liquid.

Pharmaceutical Suspension Market- Market Dynamics

Advancement in drug delivery technologies and increasing R&D investment is expected to propel market demand

Innovations in drug delivery systems and formulation technologies enhance the efficacy and stability of suspensions. Improved technologies for creating stable, high-quality suspensions help meet the needs of complex medications, which is boosting market growth. The increasing incidence of chronic conditions such as diabetes, cancer, and respiratory diseases drives the demand for various pharmaceutical formulations, including suspensions. These formulations are particularly useful for patients who need medication in a liquid form. Further, Advances in manufacturing processes, such as better mixing and milling techniques, improve the quality and consistency of pharmaceutical suspensions, making them more attractive to both manufacturers and consumers.

Increased investment in research and development by pharmaceutical companies to create new and improved formulations drives market growth. This includes developing suspensions for new drugs or improving existing products. Moreover, the demand for over the counter (OTC) medications in suspension form, such as antacids, cough syrups, and pain relievers, continues to grow, driven by consumer preference for convenient and accessible treatments.

Pharmaceutical Suspension Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2024-2032)

Based on Type segmentation, the parenteral segment was predicted to show maximum market share in the year 2023, owing to its rapid & direct route for drug delivery.

Based on Indication segmentation, the cancer segment was the leading Indication in 2023, owing to the large availability of cancer drugs.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, owing to the increasing prevalence of cancer, chronic disorders.

Based on region, North America was the leading revenue generator in 2023, due to the wide availability of suspension-based medications.

Pharmaceutical Suspension Market- Segmentation Analysis:

The Global Pharmaceutical Suspension Market is segmented based on Type, Indication, End User, and Region.

The market is divided into three categories based on Type: oral, parenteral, and others. The parenteral segment dominates the market. Advancements in parenteral drug formulations and their greater adoption are mainly boosting market growth.

The market is divided into five categories based on Indication: cancer, gastrointestinal, neurological, infectious disease, and others. The cancer segment dominates the market. The growing development in therapeutic areas and technology is stimulating segment growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The improved chronic disease treatment and therapy are proliferating segment growth.

Pharmaceutical Suspension Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is a major market due to its large population, rising healthcare expenditure, and increasing prevalence of chronic diseases. The region has countries like China, India, and Japan which are significant hubs for pharmaceutical manufacturing. The Middle East & Africa market is relatively underdeveloped compared to other regions, but there is growing interest due to increasing healthcare access and rising awareness of various treatment options.

Pharmaceutical Suspension Market- Competitive Landscape:

The pharmaceutical suspension market is significantly dynamic, with ongoing advancements and competitive strategies shaping its evolution. Companies that leverage technological innovation, and strategic partnerships. Leading companies focus on innovation to differentiate their products and maintain a competitive edge. This includes developing new formulations, improving drug delivery systems, and investing in research and development. Companies often collaborate with academic institutions and research organizations to advance the science of drug delivery and develop innovative suspension formulations.

In August 2023, Merck & Co., Inc., a leading global biopharmaceutical company, announced the approval of an expanded indication for ERVEBO for the disease called Zaire ebolavirus.

In November 2023, Teva Pharmaceutical Industries and Royalty Pharma plc, partnered to accelerate their clinical research program.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL SUSPENSION MARKET KEY PLAYERS

Pfizer Inc.
Johnson & Johnson
Novartis AG
GlaxoSmithKline (GSK)
Sanofi
Roche
Merck & Co., Inc.
Bristol-Myers Squibb
AbbVie Inc.
AstraZeneca
Amgen Inc.
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Dr. Reddy's Laboratories
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

Oral
Parenteral
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

Cancer
Gastrointestinal
Neurological
Infectious Disease
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospitals
Clinics
Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Pharmaceutical Suspension Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Pharmaceutical Suspension Market Snippet by Type
- 2.1.2. Pharmaceutical Suspension Market Snippet by Indication
- 2.1.3. Pharmaceutical Suspension Market Snippet by End User
- 2.1.4. Pharmaceutical Suspension Market Snippet by Country
- 2.1.5. Pharmaceutical Suspension Market Snippet by Region
2.2. Competitive Insights

3. Pharmaceutical Suspension Key Market Trends

3.1. Pharmaceutical Suspension Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Pharmaceutical Suspension Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Pharmaceutical Suspension Market Opportunities
3.4. Pharmaceutical Suspension Market Future Trends

4. Pharmaceutical Suspension Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Pharmaceutical Suspension Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Pharmaceutical Suspension Market Landscape

6.1. Pharmaceutical Suspension Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Suspension Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Oral
- 7.1.3. Parenteral
- 7.1.4. Others

8. Pharmaceutical Suspension Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
- 8.1.2. Cancer
- 8.1.3. Gastrointestinal
- 8.1.4. Neurological
- 8.1.5. Infectious Disease
- 8.1.6. Others

9. Pharmaceutical Suspension Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Clinics
- 9.1.4. Others

10. Pharmaceutical Suspension Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Pharmaceutical Suspension Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Pharmaceutical Suspension Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Pharmaceutical Suspension Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Pharmaceutical Suspension Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Pharmaceutical Suspension Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Suspension Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Johnson & Johnson
- 11.2.3. Novartis AG
- 11.2.4. GlaxoSmithKline (GSK)
- 11.2.5. Sanofi
- 11.2.6. Roche
- 11.2.7. Merck & Co., Inc.
- 11.2.8. Bristol-Myers Squibb
- 11.2.9. AbbVie Inc.
- 11.2.10. AstraZeneca
- 11.2.11. Amgen Inc.
- 11.2.12. Glenmark Pharmaceuticals
- 11.2.13. Teva Pharmaceutical Industries Ltd.
- 11.2.14. Mylan N.V.
- 11.2.15. Dr. Reddy's Laboratories
- 11.2.16. Others